Brillian Pharma

Executive Summary

Brillian Pharma Inc. is a privately held company based in Cambridge, MA, specializing in drug delivery technologies and pediatric drug product development. Founded in 2019, the company has established a robust R&D and cGMP quality control laboratory in New Jersey, along with a technology transfer center and an FDA-approved facility. Their stage is listed as 'Approved,' indicating they have secured regulatory clearance for at least one product or platform. By focusing on pediatric formulations, Brillian Pharma addresses a critical unmet need in drug delivery for children, leveraging their proprietary platform to enhance safety, efficacy, and compliance. Their vertically integrated operations from development to approved manufacturing position them as a potential partner for larger pharmaceutical companies seeking to expand into pediatric markets. With a strong emphasis on quality and regulatory compliance, the company is poised for growth as demand for child-friendly drug delivery solutions increases.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a strategic partnership or licensing deal for their pediatric drug delivery platform70% success
• Q4 2026FDA approval or clearance of a new pediatric drug product application60% success
• Q2 2027Expansion of manufacturing capacity or new facility announcement50% success